Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Clinical trial NCT01818726 · TERMINATED
Trial details
- NCT number
- NCT01818726
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-23
- Primary completion
- 2016-10-17
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.